Nov 17, 2025
Day One Just Made A Bold Bet On Mersana — Here’s What It Could Mean
Day One Biopharmaceuticals is acquiring Mersana Therapeutics in a deal worth up to $285M, adding a novel B7-H4–targeting ADC and strengthening its rare-cancer pipeline alongside OJEMDA’s momentum.
8 min read8' read
Hot Animals Videos 🐟
SUPPER CHANGE YOUR PLANNING POWERS
Join our newsletter 🎉
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story

More Hot Videos 🏑
s




















